Press Releases
Pharma Giant AbbVie Brings in Billions While Opposing Biden Administration Program To Bring Down Costs For Consumers
Today, pharmaceutical giant AbbVie reported $12.31 billion in revenue in Q1 2024 — all while remaining opposed to a Biden administration program designed to bring down drug prices for consumers. AbbVie CEO Richard Gonzalez has been a vocal critic of Medicare’s new negotiation authority, arguing that the ability to negotiate lower drug costs for pat